UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

Expert opinion on therapeutic targets, 2013-08, Vol.17 (8), p.921-936

2013

Link zum Volltext

Verfügbarkeit prüfen

Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets

Expert opinion on therapeutic targets, 2018-10, Vol.22 (10), p.869-877

2018

Link zum Volltext

Verfügbarkeit prüfen

Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison

Expert opinion on therapeutic targets, 2018-07, Vol.22 (7), p.639-653

2018

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia

Expert opinion on therapeutic targets, 2017-07, Vol.21 (7), p.705-714

2017

Link zum Volltext

Verfügbarkeit prüfen

AKT as a therapeutic target in multiple myeloma

Expert opinion on therapeutic targets, 2014-08, Vol.18 (8), p.897-915

2014

Link zum Volltext

Verfügbarkeit prüfen

Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery

Expert opinion on therapeutic targets, 2008-02, Vol.12 (2), p.223-238

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting disease through novel pathways of apoptosis and autophagy

Expert opinion on therapeutic targets, 2012-12, Vol.16 (12), p.1203-1214

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

Expert opinion on therapeutic targets, 2015-06, Vol.19 (6), p.795-805

2015

Link zum Volltext

Verfügbarkeit prüfen

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck

Expert opinion on therapeutic targets, 2005-08, Vol.9 (4), p.769-790

2005

Link zum Volltext

Verfügbarkeit prüfen

Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus

Expert opinion on therapeutic targets, 2006-08, Vol.10 (4), p.627-630

Doggrell, Sheila A

2006

Link zum Volltext

Verfügbarkeit prüfen

Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway

Expert opinion on therapeutic targets, 2007-12, Vol.11 (12), p.1611-1621

2007

Link zum Volltext

Verfügbarkeit prüfen

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis

Expert opinion on therapeutic targets, 2007-04, Vol.11 (4), p.443-451

2007

Link zum Volltext

Verfügbarkeit prüfen

Mammalian target of rapamycin as a therapeutic target in oncology

Expert opinion on therapeutic targets, 2008-02, Vol.12 (2), p.209-222

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting the PI3K and MAPK pathways to treat Kaposi's sarcoma-associated herpes virus infection and pathogenesis

Expert opinion on therapeutic targets, 2007-05, Vol.11 (5), p.589-599

2007

Link zum Volltext

Verfügbarkeit prüfen

Emerging molecular targets in the treatment of bacterial meningitis

Expert opinion on therapeutic targets, 2003-04, Vol.7 (2), p.141-152

Kim, Kwang Sik

2003

Link zum Volltext

Verfügbarkeit prüfen

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

Expert opinion on therapeutic targets, 2012-04, Vol.16 (S2), p.S17-S27

2012

Link zum Volltext

Verfügbarkeit prüfen

EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

Expert opinion on therapeutic targets, 2011-01, Vol.15 (1), p.63-74

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting protein kinase-b3 (akt3) signaling in melanoma

Expert opinion on therapeutic targets, 2017-03, Vol.21 (3), p.273-290

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis

Expert opinion on therapeutic targets, 2009-09, Vol.13 (9), p.1121-1134

2009

Link zum Volltext

Verfügbarkeit prüfen

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

Expert opinion on therapeutic targets, 2004-12, Vol.8 (6), p.537-550

2004

Link zum Volltext

Verfügbarkeit prüfen

K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?

Expert opinion on therapeutic targets, 2016-07, Vol.20 (7), p.831-842

2016

Link zum Volltext

Verfügbarkeit prüfen

SHIP2 and its involvement in various diseases

Expert opinion on therapeutic targets, 2010-07, Vol.14 (7), p.727-737

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy

Expert opinion on therapeutic targets, 2012-01, Vol.16 (1), p.33-48

2012

Link zum Volltext

Verfügbarkeit prüfen

AMP activated protein kinase: a next generation target for total metabolic control

Expert opinion on therapeutic targets, 2008-01, Vol.12 (1), p.91-100

Misra, Parimal

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting the PI3K and MAPK pathways to treat Kaposi s sarcoma-associated herpes virus infection and pathogenesis

Expert opinion on therapeutic targets, Vol.11 (5), p.589-599

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Online

Zeitschrift / SerieExpert Opinion On Therapeutic Targets

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(131)

Sprache

Englisch
(131)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(123)
Pharmacology & Pharmacy
(123)
Science & Technology
(123)
Humans
(121)
Animals
(87)
Antineoplastic Agents - Pharmacology
(32)
Molecular Targeted Therapy
(32)
Drug Design
(28)
Clinical Biochemistry
(27)
Drug Discovery
(27)
Molecular Medicine
(27)
Pharmacology
(27)
Signal Transduction
(25)
Signal Transduction - Drug Effects
(24)
Neoplasms - Drug Therapy
(21)
Neoplasms - Metabolism
(19)
Antineoplastic Agents - Therapeutic Use
(17)
Cancer
(14)
Signal Transduction - Physiology
(14)
Drug Delivery Systems
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Journals Complete
(131)
Taylor & Francis Current Content Access
(131)
MEDLINE
(123)

Menü

Weitere Dienste

Einstellungen

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets

Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison

Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia

AKT as a therapeutic target in multiple myeloma

Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery

Targeting disease through novel pathways of apoptosis and autophagy

Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck

Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus

Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis

Mammalian target of rapamycin as a therapeutic target in oncology

Targeting the PI3K and MAPK pathways to treat Kaposi's sarcoma-associated herpes virus infection and pathogenesis

Emerging molecular targets in the treatment of bacterial meningitis

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

Targeting protein kinase-b3 (akt3) signaling in melanoma

Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?

SHIP2 and its involvement in various diseases

Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy

AMP activated protein kinase: a next generation target for total metabolic control

Targeting the PI3K and MAPK pathways to treat Kaposi s sarcoma-associated herpes virus infection and pathogenesis

Aktive Filter

Suchergebnisse filtern